These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8071868)
1. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. Miller DB; O'Callaghan JP J Pharmacol Exp Ther; 1994 Aug; 270(2):752-60. PubMed ID: 8071868 [TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. O'Callaghan JP; Miller DB J Pharmacol Exp Ther; 1994 Aug; 270(2):741-51. PubMed ID: 8071867 [TBL] [Abstract][Full Text] [Related]
3. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Miller DB; O'Callaghan JP Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961 [TBL] [Abstract][Full Text] [Related]
4. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969 [TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system. Miller DB; O'Callaghan JP Ann N Y Acad Sci; 1996 Oct; 801():148-67. PubMed ID: 8959030 [TBL] [Abstract][Full Text] [Related]
6. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum. Chan P; Langston JW; Di Monte DA J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813 [TBL] [Abstract][Full Text] [Related]
7. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. Albers DS; Sonsalla PK J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070 [TBL] [Abstract][Full Text] [Related]
8. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
9. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Miller DB; O'Callaghan JP; Ali SF Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321 [TBL] [Abstract][Full Text] [Related]
10. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Thomas DM; Dowgiert J; Geddes TJ; Francescutti-Verbeem D; Liu X; Kuhn DM Neurosci Lett; 2004 Sep; 367(3):349-54. PubMed ID: 15337264 [TBL] [Abstract][Full Text] [Related]
11. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Itzhak Y; Martin JL; Ali SF Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724 [TBL] [Abstract][Full Text] [Related]
12. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys. Yuan J; Hatzidimitriou G; Suthar P; Mueller M; McCann U; Ricaurte G J Pharmacol Exp Ther; 2006 Mar; 316(3):1210-8. PubMed ID: 16293712 [TBL] [Abstract][Full Text] [Related]
13. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Miller DB; Ali SF; O'Callaghan JP; Laws SC Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673 [TBL] [Abstract][Full Text] [Related]
14. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. Sriram K; Miller DB; O'Callaghan JP J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514 [TBL] [Abstract][Full Text] [Related]
15. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice. Chan P; Di Monte DA; Langston JW; Janson AM J Pharmacol Exp Ther; 1997 Jan; 280(1):439-46. PubMed ID: 8996226 [TBL] [Abstract][Full Text] [Related]
16. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. Malberg JE; Sabol KE; Seiden LS J Pharmacol Exp Ther; 1996 Jul; 278(1):258-67. PubMed ID: 8764359 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Kawasaki T; Ishihara K; Ago Y; Nakamura S; Itoh S; Baba A; Matsuda T Eur J Pharmacol; 2006 Aug; 542(1-3):92-9. PubMed ID: 16784740 [TBL] [Abstract][Full Text] [Related]
18. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. Itzhak Y; Gandia C; Huang PL; Ali SF J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865 [TBL] [Abstract][Full Text] [Related]
19. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity. O'Callaghan JP; Martin PM; Mass MJ Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663 [TBL] [Abstract][Full Text] [Related]
20. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. Farfel GM; Seiden LS J Pharmacol Exp Ther; 1995 Feb; 272(2):868-75. PubMed ID: 7853205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]